SCHEMBL7607915

SCHEMBL7607915

CCCOCn1c(=O)c2c(ncn2Cc2ccccc2)n(CC2CC2)c1=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
PDE5A O76074 1/20 0.49
PDE4A P27815 1/20 0.49
PDE4B Q07343 1/20 0.49
PDE4C Q08493 1/20 0.49
PDE4D Q08499 1/20 0.49
POLB P06746 1/20 0.48
HIF1A Q16665 1/20 0.48
KMT2A Q03164 5/20 0.48
MEN1 O00255 4/20 0.48
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
ADORA2B P29275 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
ADORA3 P0DMS8 2/20 0.47
ADORA2A P29274 1/20 0.47
PDE1A P54750 1/20 0.47
PDE1B Q01064 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7605727 0.88 KMT2A (0.55) ALDH1A1POLBHIF1AKMT2AMEN1
SCHEMBL556890 0.87 PDE5A (0.63) ALDH1A1PDE5APDE4APDE4BPDE4C
SCHEMBL7606356 0.84 PDE1A (0.67) ALDH1A1POLBHIF1AKMT2AMEN1
SCHEMBL7608741 0.83 POLB (0.53) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL1457501 0.81 PDE1A (0.69) ALDH1A1PDE5APDE4APDE4BPDE4C
SCHEMBL7606543 0.81 POLB (0.57) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL7608527 0.80 POLB (0.59) ALDH1A1PDE4APDE4BPDE4CPDE4D
SCHEMBL7397039 0.78 PDE5A (0.66) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL7606542 0.78 PDE1A (0.50) ALDH1A1POLBHIF1AKMT2AMEN1
SCHEMBL1944712 0.77 POLB (0.70) ALDH1A1PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812844-B1 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AG (DE) 2002-10-23 EP disclosed
US-6214992-B1 THEOPHYLLINE DERIVATIVES HAVING AT LEAST ONE ETHER FUNCTION IN METHYL RADICAL; XANTHINE COMPOUNDS WITH THIS SUBSTITUTION PATTERN USED AS ANTISHOCK TREATMENT HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-10 US disclosed
EP-0812844-A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-17 EP disclosed